RightFit Trial Directory

Multiple Sclerosis clinical trials in Baltimore, MD

11 recruiting multiple sclerosis studies with a site in Baltimore, MD.

All trials in Baltimore, MD · All Multiple Sclerosis trials

RecruitingPhase 3NCT07325292

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Sponsor: Sanofi

Baltimore, MD · +33 more sites

RecruitingPhase 1NCT03816345

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI)

Baltimore, MD · Bethesda, MD · +48 more sites

RecruitingPhase not listedNCT06433752

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Sponsor: TG Therapeutics, Inc.

Baltimore, MD · Glen Burnie, MD · +107 more sites

RecruitingNot applicableNCT06796504

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Sponsor: SetPoint Medical Corporation

Baltimore, MD · +8 more sites

RecruitingPhase 1 / Phase 2NCT06063850

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

Sponsor: UniQure Biopharma B.V.

Baltimore, MD · Bethesda, MD · +16 more sites

RecruitingNot applicableNCT06864936

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Sponsor: University of Maryland, Baltimore

Baltimore, MD

RecruitingPhase 2NCT07497399

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Sponsor: Johns Hopkins University

Baltimore, MD · +1 more sites

RecruitingPhase 2NCT06170970

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Sponsor: Johns Hopkins University

Baltimore, MD

RecruitingPhase 4NCT07389590

Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

Sponsor: Johns Hopkins University

Baltimore, MD

RecruitingPhase 1NCT07221240

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

Sponsor: PRG Science & Technology Co., Ltd.

Baltimore, MD

Not yet recruitingPhase 1NCT07221799

OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis

Sponsor: University of Maryland, Baltimore

Baltimore, MD

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.